Risk factors for DKA in individuals with type 2 diabetes treated with SGLT2 inhibitors include very-low-carbohydrate diets and prolonged fasting, dehydration, excessive alcohol intake and the presence of autoimmunity, in addition to typical precipitating factors [94, 95]. Here, SLC5A2 is linked to type 2 diabetes mellitus.